Publications
Publications
Show Results For
- All HBS Web
(22,022)
- Faculty Publications (7,305)
- June 2023
- Teaching Note
Connecting Students in Chattanooga (A) and (B)
By: Jan W. Rivkin
Teaching Note for HBS Case Nos. 722-449 and 722-451. As this case opens, it is the spring of 2020 in Chattanooga. COVID-19 has hit, public schools have closed their buildings, remote learning has begun, and more than 28,000 schoolkids lack the high-quality Internet... View Details
- June 12, 2023
- Article
The Limits of Capacity Building for Investment Contract Negotiations
By: Karl P. Sauvant, Vanessa Sze Wai Tsang and Louis T. Wells
Developing countries must negotiate the best possible investment contracts with foreign investors at the outset. Donor organizations regularly push for “capacity building” to create technical expertise for negotiations within host country governments. But building and... View Details
- June 2023
- Case
Block: Creating an Ecosystem of Ecosystems
By: Lauren Cohen, Richard Ryffel, Grace Headinger and Ruoshi Qi
At Investor Day 2022, Block announced a new vision for its businesses: creating an ecosystem of ecosystems. Outside the norm for many public growth companies, Block had recently acquired a variety of new business streams in the creator economy and Bitcoin despite a... View Details
Keywords: Business Growth; Fintech; Company Management; Growth Strategy; Innovation And Strategy; Acquisition; Business Growth and Maturation; Business Model; Change; Finance; Growth Management; Growth and Development Strategy; Innovation Strategy; Technological Innovation; Communication Strategy; Corporate Strategy; Business Strategy; Financial Services Industry; Technology Industry; United States; California; San Francisco
- 2023
- Working Paper
Evaluation and Learning in R&D Investment
By: Alexander P. Frankel, Joshua L. Krieger, Danielle Li and Dimitris Papanikolaou
We examine the role of spillover learning in shaping the value of exploratory versus incremental
R&D. Using data from drug development, we show that novel drug candidates generate more
knowledge spillovers than incremental ones. Despite being less likely to reach... View Details
- June 2023
- Supplement
Leading with Trust: Sarah Al-Suhaimi Video Supplement
By: Sandra J. Sucher, Sarah Livick-Moses and Dave Habeeb
This supplement features video interviews with Sarah Al Suhaimi, CEO of NCB Capital, the investment arm of Saudi's largest bank. View Details
- 2023
- Working Paper
Design-Based Confidence Sequences: A General Approach to Risk Mitigation in Online Experimentation
By: Dae Woong Ham, Michael Lindon, Martin Tingley and Iavor Bojinov
Randomized experiments have become the standard method for companies to evaluate the performance of new products or services. In addition to augmenting managers’ decision-making, experimentation mitigates risk by limiting the proportion of customers exposed to... View Details
- June 2023
- Article
Gaining Organizational Adoption: Strategically Pacing the Deployment of Digital Innovations
By: Rebecca Karp
Scholars have long suggested that to foster adoption for their innovative products and services, entrepreneurs should engage with customers to better understand their unmet needs. Yet, customers frequently reside in organizations, and organizational members may not be... View Details
- June 2023
- Article
National Customer Orientation: An Empirical Test across 112 Countries
By: Ofer Mintz, Imran S. Currim and Rohit Deshpandé
Customer orientation is a central tenet of marketing. However, less is known about how customer orientation varies across countries and time. Mintz, Currim, and Deshpandé (Eur. J. Mark., 56: 1014–1041, 2022) propose a country-level construct, national customer... View Details
- May–June 2023
- Article
The High Cost of Neglecting Low-Wage Workers: Six Mistakes That Companies Make—and How They Can Do Better
By: Joseph Fuller and Manjari Raman
Many companies blame outside factors for the trouble they’ve been having in finding and retaining frontline workers: the pandemic, the government’s stimulus checks, the intrinsic nature of low-wage work. The authors argue that in fact the real problem lies in six big... View Details
- June, 2023
- Article
Walking the Purpose-Talk Inside a Large Company: Sustainable Product Development as an Instance of Divergent Change
By: Marissa Kimsey, Thijs Geradts and Julie Battilana
There is a growing interest in large companies pursuing a new purpose—changing their core reason for being from a singular focus on financial gain to a renewed responsibility to people and the planet alongside profit. Yet knowledge of how a large company can walk that... View Details
- 2023
- Article
Exploiting Discovered Regression Discontinuities to Debias Conditioned-on-observable Estimators
By: Benjamin Jakubowski, Siram Somanchi, Edward McFowland III and Daniel B. Neill
Regression discontinuity (RD) designs are widely used to estimate causal effects in the absence of a randomized experiment. However, standard approaches to RD analysis face two significant limitations. First, they require a priori knowledge of discontinuities in... View Details
- May 2023 (Revised November 2023)
- Case
Arcos Dorados: Decarbonizing McDonald's in Latin America
By: George Serafeim, Michael W. Toffel, Jenyfeer Martinez Buitrago and Mariana Cal
This case describes the decarbonization strategy of Arcos Dorados—McDonald’s largest independent franchisee, operating in 20 countries and territories in Latin America and the Caribbean—and how the company measured its greenhouse gas (GHG) emissions, including those... View Details
Keywords: Environmental Accounting; Animal-Based Agribusiness; Plant-Based Agribusiness; Change Management; Forecasting and Prediction; Environmental Sustainability; Food; Growth Management; Supply Chain; Corporate Social Responsibility and Impact; Strategy; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry; Latin America; North and Central America; South America
- May 2023
- Case
Legacy Partners
By: Royce Yudkoff and Richard S. Ruback
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021. The company, based in Sacramento CA, was a compounding pharmacy serving Total Parenteral Nutrition ("TPN") patients nationwide.... View Details
- May 2023
- Supplement
Alicia Keys and Swizz Beats Video Supplement Playlist
By: Boris Groysberg
- May 17, 2023
- Article
Don't Let Passion Lead to Burnout on Your Team
By: Joy Bredehorst, Kai Krautter, Jirs Meuris and Jon M. Jachimowicz
Passion is often heralded as the key to a fulfilling and successful career, but the authors’ recent research suggests that it can also come at a cost: Feeling passionate about work can lead to exhaustion and even burnout. Through studies with more than 700 employees... View Details
- May 2023
- Teaching Note
Away: Scaling a DTC Travel Brand
By: Joseph B. Fuller and Jill Avery
Teaching Note for HBS Case No. 520-051. Away, a direct-to-consumer, digital native e-commerce seller of travel luggage, is debating how to invest its latest round of venture funding. How quickly could and should Away scale and what were the most promising growth... View Details
- May 2023
- Course Overview Note
Space: Public and Commercial Economics (SPACE)
SPACE is a course with two goals: to use the tools of economics to better understand the rapidly evolving space sector, and to train the next generation of commercial space leaders. We pursue these goals through a systematic study of the growing space economy,... View Details
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details